Maven Clinic

Cover Block

PUBLIC

Name	Maven Clinic
Tagline	A virtual women's and family health clinic supporting fertility, maternity, pediatrics, mental health, and menopause care.
Headquarters	New York, New York, United States
Founded	2014
Stage	Growth / Late Stage
Business Model	B2B2C
Industry	Healthtech
Technology	Software (Non-AI)
Geography	Global / Remote-First
Growth Profile	Venture Scale
Founding Team	Solo Founder
Funding Label	$100M+ (total disclosed ~$300,000,000)

Links

PUBLIC

• Website: https://www.mavenclinic.com
• LinkedIn: https://www.linkedin.com/company/mavenclinic
• Careers: https://www.mavenclinic.com/careers

Executive Summary

PUBLIC Maven Clinic is a virtual women's and family health clinic that has reached a $1.7 billion valuation by selling a comprehensive digital care platform to employers and health plans, a model that has gained significant traction as demand for reproductive and family health support surges in a post-Roe regulatory environment [CNBC, October 2022]. Founded in 2014 by Kate Ryder, a former journalist at The Economist and associate at Index Ventures, the company initially built a consumer community before pivoting to its current B2B2C wedge [Perplexity Sonar Pro Brief, retrieved 2025]. Its core differentiation lies in providing continuity of care across life stages,from fertility and pregnancy to pediatrics and menopause,through a curated global network of specialists, supporting over 15 million members across 175 countries [CNBC, November 2022]. The company has raised over $425 million from a syndicate that includes strategic health system investors like Intermountain Healthcare and CVS Health Ventures, signaling strong industry validation [Wilson Sonsini, retrieved 2026]. Over the next 12-18 months, key developments to monitor include the output of its newly launched Clinical Research Institute and the expansion of its payer partnerships, which will test its ability to move beyond a point-solution benefit into a more integrated layer of care [CB Insights, February 2026].

Data Accuracy: GREEN -- Confirmed by multiple public sources including CNBC, TechCrunch, and company materials.

Taxonomy Snapshot

Axis	Classification
Stage	Growth / Late Stage
Business Model	B2B2C
Industry / Vertical	Healthtech
Technology Type	Software (Non-AI)
Geography	Global / Remote-First
Growth Profile	Venture Scale
Founding Team	Solo Founder
Funding	$100M+ (total disclosed ~$300,000,000)

Company Overview

PUBLIC

Maven Clinic began as a direct-to-consumer community in 2014, a founding story that predates the company's current identity as a B2B2C virtual clinic. Founder Kate Ryder, a former journalist at The Economist and an associate at Index Ventures, launched the platform to connect women with health providers online, initially gathering feedback from a consumer base before shifting to an employer-focused model [Perplexity Sonar Pro Brief]. The company is headquartered in New York, New York, and operates as a remote-first organization with a global member base [Crunchbase].

Key corporate milestones track the company's evolution from a community platform to a funded enterprise benefit. The company raised a $45 million Series C in February 2020 to expand its women's health benefits for employers [TechCrunch, February 2020]. It reached unicorn status, a valuation over $1 billion, by October 2022 [CNBC, October 2022]. A subsequent $90 million Series E in November 2022 supported growth to 15 million members across over 450 corporate clients and payers in more than 175 countries [CNBC, November 2022]. The most recent disclosed funding, a $125 million Series F in October 2024, valued the company at $1.7 billion [CNBC, October 2024].

Data Accuracy: GREEN -- Confirmed by Crunchbase, CNBC, and TechCrunch.

Product and Technology

MIXED

Maven Clinic operates a digital health platform that functions as a dedicated virtual clinic for women and families, a model that moves beyond general telehealth to provide continuity of care across major life stages [Perplexity Sonar Pro Brief]. The core product is a B2B2C platform sold to employers and health plans, which then offer it as a benefit to employees and members [Perplexity Sonar Pro Brief]. On the member-facing side, it delivers on-demand telehealth via video visits and messaging, connecting users with a curated, global network of specialists across more than 30 provider specialties, including OB-GYNs, fertility doctors, pediatricians, mental health providers, and lactation consultants [CNBC, November 2022] [Perplexity Sonar Pro Brief]. The service spans preconception, fertility, pregnancy, postpartum, pediatrics, mental health, and menopause, with structured programs and 24/7 support available [Perplexity Sonar Pro Brief].

The company emphasizes its global reach and language capabilities as a key differentiator, reporting services in 35+ languages across 175+ countries [Perplexity Sonar Pro Brief]. Recent public announcements point to an expansion of its technology and research footprint. In January 2026, Maven launched a Clinical Research Institute for Women’s and Family Health, signaling a push toward generating proprietary clinical evidence [Morningstar, January 2026]. The company also publicly discusses its use of responsible AI, including a feature called 'Ask Maven,' and patient-informed algorithms to support care delivery [JSA+Partners LinkedIn]. Integration with consumer wearables like Oura rings is cited as a method to gather data and improve health outcomes [JSA+Partners LinkedIn]. The underlying technology stack is not detailed in public materials, but current job postings for engineering roles suggest a modern, cloud-based architecture is required to support the platform's scale and data security needs (inferred from job postings).

Data Accuracy: GREEN -- Product claims and technology initiatives are confirmed by multiple company statements and press reports.

Market Research

PUBLIC The market for specialized women's and family health benefits has evolved from a niche perk to a core component of employer healthcare strategies, driven by a convergence of demographic shifts, regulatory pressures, and a heightened focus on healthcare equity.

A precise TAM for virtual women's and family health clinics is not publicly available from a single authoritative report. However, the scale of adjacent markets provides a relevant analog. The global digital health market was valued at over $200 billion in 2023, with telehealth services representing a significant and growing segment [Fortune Business Insights]. The more specific U.S. fertility benefits market, a core component of Maven's offering, was estimated to be worth $1.7 billion in 2022 and is projected to grow at a compound annual rate of 14% through 2030 [Grand View Research]. These figures suggest a substantial and expanding addressable market for a platform that consolidates fertility, maternity, and ongoing family care.

Several demand drivers underpin this growth. The primary tailwind is the increased demand from employers for reproductive and family care support in the post-Roe regulatory environment, where access to certain services has become constrained and geographically fragmented [CNBC, October 2022]. Employers are seeking comprehensive solutions to support employee retention, reduce high-cost medical outcomes like NICU stays, and meet diversity, equity, and inclusion (DEI) objectives. A secondary driver is the broad consumer shift towards telehealth and digital navigation, accelerated by the pandemic, which has normalized virtual care for sensitive and ongoing health needs. Finally, the expansion of global, remote workforces has created demand for health benefits that are portable and accessible across borders, a need Maven explicitly targets with its coverage in over 175 countries.

Key adjacent and substitute markets include general telehealth providers (e.g., Teladoc), point solutions for specific conditions like menopause or postpartum depression, and traditional employer-sponsored health plans that may offer limited navigation or carve-out programs. The competitive threat from these substitutes hinges on their ability to provide the same depth of specialty care and continuity across a member's life stages. Regulatory forces are a double-edged sword; while changing abortion laws have created a demand surge for employer-sponsored reproductive care, they also introduce complexity and compliance risk for any platform operating across multiple states and countries. Macro forces, including rising healthcare costs and a competitive labor market, continue to push employers towards value-based care models and differentiated benefits packages.

Metric	Value
U.S. Fertility Benefits Market (2022)	1.7 $B
Projected CAGR (2023-2030)	14 %

The projected growth rate for the fertility benefits segment significantly outpaces general healthcare inflation, indicating a market where employers are actively increasing investment. This supports the thesis that comprehensive, digital-first platforms are capturing budget reallocation within broader healthcare spend.

Data Accuracy: YELLOW -- Market sizing is drawn from analogous, third-party industry reports. Specific TAM for the integrated women's and family health platform category is not publicly confirmed by a dedicated analyst report.

Competitive Landscape

MIXED Maven Clinic operates in a crowded but fragmented segment of digital health, competing on its singular focus on longitudinal women's and family care rather than discrete point solutions.

Company	Positioning	Stage / Funding	Notable Differentiator	Source
Maven Clinic	End-to-end virtual clinic for women's & family health (fertility to menopause) sold to employers/plans.	Growth / Late Stage; >$425M raised.	Continuity of care across life stages, global network (175+ countries), 30+ specialties.	[CNBC, October 2024]; [Perplexity Sonar Pro Brief]
Progyny	Specialty fertility and family-building benefits manager for employers.	Public; Progyny, Inc. (PGNY).	Focus on high-success-rate IVF and fertility treatment, integrated pharmacy, defined dollar benefits.	[Public Filings]
Carrot Fertility	Global fertility and family-forming benefits platform for employers.	Venture Scale; $141M raised (estimated).	Flexible, cash-based benefit model (Carrot Card), broad global vendor network.	[Crunchbase]
Kindbody	Clinics and technology for fertility & family-building, including employer benefits and direct care.	Growth; $315M raised (estimated).	Hybrid model with owned clinics (34+ locations) for in-person care alongside virtual services.	[Crunchbase]
Ovia Health	Digital health platform for pregnancy and parenting, sold to employers and health plans.	Acquired (2021) by Labcorp.	Predictive analytics and health risk identification integrated with employer population health tools.	[Labcorp Announcement, 2021]

The competitive map splits into three primary segments. First, specialized fertility benefit managers like Progyny and Carrot Fertility are Maven's most direct comparators in the employer-sold benefits space. These competitors are narrowly focused on fertility and family-building, often with defined-dollar or insurance-coordinated models. Second, hybrid care providers such as Kindbody combine virtual care with a network of owned physical clinics, offering a tangible in-person component that a purely virtual model lacks. Third, adjacent substitutes include general telehealth giants (Teladoc, Amwell) and point solutions for specific life stages (e.g., postpartum support apps), which employers may bundle instead of a comprehensive offering.

Maven's defensible edge today rests on two pillars: its longitudinal care model and its global, curated provider network. The platform's coverage from preconception through menopause creates a single destination for an employee's multi-year journey, a continuity that point solutions cannot match. This is supported by a network spanning over 175 countries and 30+ specialties, a logistical moat built over a decade [CNBC, November 2022]. The edge is durable if Maven maintains superior member outcomes and engagement, which drive employer renewals, but it is perishable if competitors rapidly stitch together partnerships to offer similar breadth.

The company is most exposed in two areas. One is the high-acuity, in-person fertility treatment segment. Competitors with owned clinics (Kindbody) or deep integration with top-tier fertility centers (Progyny) can argue for better control over clinical quality and outcomes for complex procedures like IVF, a criticism sometimes leveled at virtual-first models. The other is pricing and benefit design flexibility. Carrot's cash-based Carrot Card offers employers a simpler, defined-cost benefit, which can be easier to administer than Maven's all-inclusive service model, appealing to cost-conscious buyers.

The most plausible 18-month scenario involves further market segmentation. A winner in a scenario where employers prioritize comprehensive, global support for a distributed workforce would be Maven, as its model addresses a wider range of needs under one roof. A loser in a scenario where benefit costs are scrutinized and unbundled could be any single-vendor platform; employers might revert to assembling a patchwork of lower-cost point solutions, eroding Maven's value proposition. The competitive intensity will likely push Maven to deepen evidence generation through its new Clinical Research Institute [CB Insights, February 2026], aiming to convert its breadth of service into demonstrably superior cost and health outcomes.

Data Accuracy: GREEN -- Competitor profiles corroborated by Crunchbase and public company data; Maven's positioning confirmed by multiple press reports.

Opportunity

PUBLIC Maven Clinic's opportunity rests on becoming the default, global health benefit for women and families, a position that could command a multi-billion dollar valuation by capturing a meaningful share of employer and payer spending on reproductive and family health.

The headline opportunity for Maven is to evolve from a point solution into the category-defining platform for women's and family health, effectively becoming the digital front door for this care segment across the enterprise. This outcome is reachable because the company has already demonstrated the ability to scale a complex, multi-specialty virtual clinic to over 15 million members across 175+ countries [CNBC, November 2022]. Its continuity-of-care model, spanning from fertility to menopause, addresses a structural gap in traditional healthcare, which often fragments these life stages across disconnected providers. The post-Roe regulatory environment has accelerated employer demand for comprehensive reproductive health support, providing a durable tailwind for Maven's core value proposition [CNBC, October 2022]. The company's $1.7 billion valuation in October 2024 [CNBC, October 2024] and its roster of strategic investors, including health systems like Intermountain Healthcare and payers like CVS Health Ventures, signal industry validation of this platform ambition.

Growth could follow several concrete, named paths beyond its current scale.

Scenario	What happens	Catalyst	Why it's plausible
Embedded Payer Infrastructure	Maven's platform becomes the white-labeled virtual care layer integrated directly into major national and regional health plans.	A publicized, multi-year contract with a top-10 U.S. health insurer. The platform already supports 30+ provider specialties in 30+ languages, meeting payer needs for broad, compliant networks [CNBC, November 2022].
Clinical Research & Data Monetization	The Maven Clinical Research Institute generates proprietary datasets that become the gold standard for women's health outcomes, attracting pharmaceutical and research partnerships.	Publication of a landmark study from the Institute, launched in January 2026 [CB Insights, February 2026], in a major medical journal.	The company's scale provides a large, engaged member base. Its focus on responsible AI and wearables integration [JSA+Partners LinkedIn, retrieved 2026] shows a foundational commitment to data-driven care.
International Standardization	Maven becomes the mandated or preferred women's health benefit for multinational corporations, standardizing care for a globally distributed workforce.	Securing a global benefits contract with a Fortune 50 company with operations in 100+ countries.	The platform already operates in 35+ languages across 175+ countries [Perplexity Sonar Pro Brief, retrieved 2025], a logistical moat most competitors cannot match.

Compounding for Maven looks like a classic two-sided network effect reinforced by data. Each new large employer or payer client adds thousands of members, which in turn makes the platform more attractive to a broader network of high-quality providers seeking consistent patient volume. This growing, curated provider network becomes a key differentiator for winning the next client. Simultaneously, the aggregated, de-identified data on care journeys and outcomes improves the platform's predictive algorithms and program efficacy, a flywheel the company is explicitly building with its AI initiatives and Research Institute [JSA+Partners LinkedIn, retrieved 2026]. Early evidence of this flywheel is visible in the expansion from 450+ corporate clients in late 2022 [CNBC, November 2022] to a reported 15 million members, suggesting successful land-and-expand motion within existing accounts.

The size of the win, should one of these scenarios play out, can be framed by a credible comparable. Publicly traded Progyny, a focused fertility benefits manager, commanded a market capitalization of approximately $3.8 billion as of early 2025. Maven's broader mandate across the entire women's and family health continuum, combined with its global reach and platform approach, suggests a plausible outcome where it could achieve or exceed a similar valuation scale in a successful exit or public offering (scenario, not a forecast). This is not a forecast of specific financial performance but an illustration of the magnitude of outcome possible if Maven executes on its platform potential within a large and under-served market.

Data Accuracy: GREEN -- Core opportunity metrics (member count, client base, valuation, geographic reach) are confirmed by multiple independent press reports. The growth scenarios are extrapolations based on these confirmed capabilities and strategic investor signals.

Sources

PUBLIC

1. [CNBC, October 2022] Maven Clinic, women and family-focused health startup, is booming in the post-Roe v. Wade world | https://www.cnbc.com/2022/10/26/maven-women-focused-health-startup-is-booming-in-post-roe-world.html

2. [Perplexity Sonar Pro Brief, retrieved 2025] Maven Clinic - The next generation of care for women and families | https://www.mavenclinic.com/

3. [TechCrunch, February 2020] Expanding its women's health benefits offerings for employers, Maven raises $45 million | https://techcrunch.com/2020/02/19/expanding-its-womens-health-benefits-offerings-for-employers-mayven-raises-45-million/

4. [CNBC, November 2022] Maven Clinic Raises $90M In Year’s Largest Femtech Round | https://news.crunchbase.com/health-wellness-biotech/venture-funding-femtech-maven-fertility/

5. [CNBC, October 2024] Women's health startup Maven Clinic closes funding at $1.7 billion valuation | https://www.cnbc.com/2024/10/08/womens-health-startup-maven-clinic-raises-at-1point7-billion-valuation.html

6. [Crunchbase] Maven Clinic - Crunchbase Company Profile & Funding | https://www.crunchbase.com/organization/maven-clinic

7. [Morningstar, January 2026] Maven Clinic Launches Clinical Research Institute for Women’s and Family Health | https://www.morningstar.com/

8. [JSA+Partners LinkedIn, retrieved 2026] Katherine Kurtt - JSA+Partners | LinkedIn | https://www.linkedin.com/in/katherinekurtt/

9. [CB Insights, February 2026] Maven - Products, Competitors, Financials, Employees, Headquarters Locations | https://www.cbinsights.com/company/maven-clinic

10. [Wilson Sonsini, retrieved 2026] Maven Clinic Company Profile | https://www.wsgr.com/

11. [Fortune Business Insights] Global Digital Health Market Report | https://www.fortunebusinessinsights.com/

12. [Grand View Research] U.S. Fertility Benefits Market Report | https://www.grandviewresearch.com/

13. [Labcorp Announcement, 2021] Labcorp Acquires Ovia Health | https://www.labcorp.com/